Lexaria’s Human Nicotine Study Nearing Start Date
https://www.accesswire.com/708333/Lexarias-Human-Nicotine-Study-Nearing-Start-Date
67 Biggest Movers From Yesterday
Gainers
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.4% to close at $10.30 as the company agreed to be taken private by TPG Capital.
Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday.
Why Shares Of Lexaria Biosciences Are Trading Higher
Lexaria Bioscience Corp. (NASDAQ: LEXX) shares are trading higher after the company announced manufacturing and license agreements with BevNology.
Dow Jumps 550 Points; Convey Health Solutions Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 550 points on Tuesday.
45 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) shares jumped 138.8% to $10.31 as the company agreed to be taken private by TPG Capital,.
Lexaria Grants License To AnodGen Bioceuticals
KELOWNA, BC / ACCESSWIRE / June 8, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the
Lexaria Files Pre-IND Meeting Request Letter With FDA
Lexaria Files Pre-IND Meeting Request Letter with U.S. FDA
KELOWNA, BC / ACCESSWIRE / June 6, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global
LEXX: Hypertension Results Raise Stakes
By John Vandermosten, CFA
NASDAQ:LEXX
READ THE FULL LEXX RESEARCH REPORT
Lexaria Posied To Receive US Patent For DehydraTECH To Deliver Antiviral Drugs
Lexaria Bioscience Corp (NASDAQ:LEXX) is receiving its first-ever patent for DehydraTECH technology in the enhanced delivery of antiviral drugs. Lexaria has…